New treatment option for Pediatric Obesity
Official title Monitoring Eating Across Locations (MEAL) - Timing, Intake, and Mealtime Evaluation (TIME)
ClinicalTrials.gov ID: NCT07095166
What this study is testing
- What it's testing
- Increased availability of high-energy dense foods has contributed to a pediatric obesity epidemic, with 23% of United States children currently presenting with the disease. How children eat contributes to both overconsumption and greater adiposity.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 9. Healthy volunteers may be eligible.
You may be able to join if
- children must be between the ages of 6-9 years-old
- children are of good health with no learning disabilities (e.g., ADHD, determined by parent report)
- children are not on any medications known to impact body weight, taste, food intake, behavior, or blood flow
- parents report that children like and are willing to eat study foods
You likely can't join if
- Children are not within the age requirements (\ 9 years old)
- If children are taking cold or allergy medication, or other medications known to influence cognitive function, taste, appetite, or blood flow.
- If children don't speak English.
- If children are colorblind.
- If children have a learning disability, ADD/ADHD, language delays, autism or other neurological or psychological conditions.
- If children have a pre-existing medical condition such as type I or type II diabetes, rheumatoid arthritis, Cushing's syndrome, Down's syndrome...
See the full eligibility criteria
- children must be between the ages of 6-9 years-old
- children are of good health with no learning disabilities (e.g., ADHD, determined by parent report)
- children are not on any medications known to impact body weight, taste, food intake, behavior, or blood flow
- parents report that children like and are willing to eat study foods
- Children are not within the age requirements (\ 9 years old)
- If children are taking cold or allergy medication, or other medications known to influence cognitive function, taste, appetite, or blood flow.
- If children don't speak English.
- If children are colorblind.
- If children have a learning disability, ADD/ADHD, language delays, autism or other neurological or psychological conditions.
- If children have a pre-existing medical condition such as type I or type II diabetes, rheumatoid arthritis, Cushing's syndrome, Down's syndrome, severe lactose intolerance, Prader-Willi syndrome, HIV, cancer, renal...
- If children are allergic to foods or ingredients used in the study.
- child received an X-ray in the previous year (to avoid excess radiation exposure due to the DXA scans performed in the research)
The study team makes the final eligibility decision.
Where it's taking place
- State College, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 9 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include State College, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.